文献速递关节外科

慢性MRSA携带者确认根除后择期髋膝关节置换手术部位感染风险

Risk of Surgical Site Infection in Elective Hip and Knee Replacements After Confirmed Eradication of MRSA in Chronic Carriers.
PubMed 文献 · J Arthroplasty · 2017-06-29

该回顾性分析纳入6613例择期全髋或全膝关节置换患者,MRSA定植率1.3%(83例),其中79例术前确认根除。根除后79例中5例(6.32%,95%CI 2.35%-14.79%)发生深部SSI,THA中2例MRSA感染(相对风险4.46,95%CI 1.12-17.82),TKA中2例MRSA和1例MSSA感染(相对风险5.61,95%CI 1.81-17.38),均高于非MRSA携带者。

要点

  • MRSA定植者根除后THA深部SSI相对风险4.46(95%CI 1.12-17.82),高于非携带者。
  • MRSA定植者根除后TKA深部SSI相对风险5.61(95%CI 1.81-17.38),高于非携带者。
  • 79例确认根除者中5例(6.32%,95%CI 2.35%-14.79%)术后1年内发生深部SSI。

核心结论

  • 尽管对MRSA携带者进行选择性治疗并确认根除,接受髋或膝关节置换的MRSA定植患者手术部位感染风险仍显著增加。

研究设计与样本

  • 回顾性分析,纳入本机构6613例择期全髋关节置换(THA,n=3347)和全膝关节置换(TKA,n=3266)患者,识别术前MRSA定植队列并与非MRSA携带者比较感染率。

主要发现

  • MRSA定植率为1.3%(83例),其中79例术前确认根除携带状态,包括38例THA和41例TKA。
  • 79例确认根除者中5例(6.32%;95%CI 2.35%-14.79%)术后1年内发生深部SSI。
  • THA中发生2例MRSA感染,相对风险4.46(95%CI 1.12-17.82)。
  • TKA中发生2例MRSA和1例甲氧西林敏感金黄色葡萄球菌感染,相对风险5.61(95%CI 1.81-17.38)。
  • 同期MRSA阴性对照组THA深部脓毒症率为1.17%,TKA为1.3%,与MRSA定植根除组感染率差异有统计学意义。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Methicillin-resistant Staphylococcus aureus (MRSA) is globally endemic and is a leading cause of surgical site infection (SSI). The purpose of this study was to evaluate the incidence of SSI in MRSA carriers undergoing elective hip or knee arthroplasty, who had confirmed eradication and to compare it with incidence of SSI in non-MRSA carriers. METHODS: This is a retrospective analysis of 6613 patients who underwent elective total hip arthroplasty (THA; n = 3347) and total knee arthroplasty (TKA; n = 3266) at our institution. A cohort of patients who were preoperatively colonized with MRSA was identified. We compared the infection rates with non-MRSA carriers. RESULTS: We had a colonization rate of 1.3% (83 patients). A total of 79 patients had confirmed eradication of carrier status before surgical intervention. Of these, 38 were THAs and 41 were TKAs. Five of 79 patients (6.32%; 95% confidence interval [CI]: 2.35%-14.79%) had "deep SSI" within 1 year of surgery. There were 2 MRSA infections in THAs (relative risk 4.46; 95% CI: 1.12-17.82). There were 2 MRSA and 1 methicillin-sensitive Staphylococcus aureus infections in TKAs (relative risk 5.61; 95% CI: 1.81-17.38). A significant statistical difference in infection rates from MRSA negative control group was noted, which had a deep sepsis rate of 1.17% in THAs and 1.3% in TKAs over the same period. CONCLUSION: In spite of a selective treatment program for carriers and confirmed eradication, there is still a significantly increased risk of SSI in MRSA-colonized patients undergoing hip or knee arthroplasties.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Tandon T, Tadros BJ, Akehurst H, et al. Risk of Surgical Site Infection in Elective Hip and Knee Replacements After Confirmed Eradication of MRSA in Chronic Carriers. J Arthroplasty. 2017. PMID: 28739308. doi:10.1016/j.arth.2017.06.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。